KR920016093A - 흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화 - Google Patents

흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화 Download PDF

Info

Publication number
KR920016093A
KR920016093A KR1019920001736A KR920001736A KR920016093A KR 920016093 A KR920016093 A KR 920016093A KR 1019920001736 A KR1019920001736 A KR 1019920001736A KR 920001736 A KR920001736 A KR 920001736A KR 920016093 A KR920016093 A KR 920016093A
Authority
KR
South Korea
Prior art keywords
inhaled
nonsteroidal anti
inflammatory drugs
enhancement
reactive
Prior art date
Application number
KR1019920001736A
Other languages
English (en)
Inventor
비앙코 세바스티아노
Original Assignee
엔겔하르트, 라피체
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엔겔하르트, 라피체, 훽스트 아크티엔게젤샤프트 filed Critical 엔겔하르트, 라피체
Publication of KR920016093A publication Critical patent/KR920016093A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 천식환자 7명의 그룹에 대해 상이한 처리를 한후 증류수의 UNW의 상이한 용량에서의 기본선에 비해 평균 FEV1이 감소하는 것을 도시한 것이다. 제2도는 L-ASA 및 푸로세마이드를 단독으로 및 혼합하여 에어로졸 치료한 후 평균 PD15대 UNW를 도시한 것이다.

Claims (10)

  1. 천식 치료용 흡입제 제조를 위한 루프 이뇨제와 비스테로이드성 소염약제의 혼합물의 용도.
  2. 제1항에 있어서, 비스테로이드성 소염약제가 사이클로옥시게나제 억제제인 용도.
  3. 제1항 또는 제2항에 있어서, 루프 이뇨제가 푸로세마이드인 용도.
  4. 제1항 또는 제2항에 있어서, 루프 이뇨제가 피레타나이드인 용도.
  5. 제1항 내지 제4항중 어느 한 항에 있어서, 비스테로이드성 소염약제가 아세틸살리실산인 용도.
  6. 천식 치료시 흡입에 의해 도포하기 위한 루프 이뇨제 및 비스테로이드성 소염약제의 혼합물.
  7. 제6항에 있어서, 아세틸살리실산 및 푸로세마이드를 함유하는 혼합물.
  8. 제6항에 있어서, 인도메타신 및 푸로세마이드를 함유하는 혼합물.
  9. 제6항에 있어서, 케토프로펜 및 푸로세마이드를 함유하는 혼합물.
  10. 제6항에 있어서, 테녹시캄 및 푸로세마이드를 함유하는 혼합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920001736A 1991-02-09 1992-02-07 흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화 KR920016093A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91101817 1991-02-09
EP91101817.4 1991-02-09

Publications (1)

Publication Number Publication Date
KR920016093A true KR920016093A (ko) 1992-09-24

Family

ID=8206392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920001736A KR920016093A (ko) 1991-02-09 1992-02-07 흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화

Country Status (15)

Country Link
US (2) US5366967A (ko)
EP (1) EP0499142A3 (ko)
JP (1) JPH0680587A (ko)
KR (1) KR920016093A (ko)
AU (1) AU652798B2 (ko)
BR (1) BR9200430A (ko)
CA (1) CA2060954A1 (ko)
CS (1) CS35392A3 (ko)
HU (1) HU209609B (ko)
IE (1) IE920426A1 (ko)
IL (1) IL100897A0 (ko)
MX (1) MX9200570A (ko)
NO (1) NO920503L (ko)
NZ (1) NZ241541A (ko)
ZA (1) ZA92891B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499143B1 (en) * 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
HU219899B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban
EP1870122A3 (en) 1995-04-14 2008-03-12 SmithKline Beecham Corporation Metered dose inhaler
JP3573213B2 (ja) 1995-04-14 2004-10-06 グラクソ、ウェルカム、インコーポレーテッド ベクロメタゾンジプロピオネート用計量投与用吸入器
NZ306280A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
WO2002092946A1 (en) * 2001-05-11 2002-11-21 Ray Robert Shorey Temporary rooftop and stairway safety rail system
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
EP3607941A1 (en) 2013-04-30 2020-02-12 Otitopic Inc. Dry powder formulations and methods of use
PL3107548T3 (pl) 2014-02-20 2022-10-31 Otitopic Inc. Suche formulacje w proszku do inhalacji

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Also Published As

Publication number Publication date
CS35392A3 (en) 1992-08-12
NO920503L (no) 1992-08-10
JPH0680587A (ja) 1994-03-22
HU9200390D0 (en) 1992-04-28
MX9200570A (es) 1994-07-29
AU1077092A (en) 1992-08-13
US5750559A (en) 1998-05-12
EP0499142A2 (en) 1992-08-19
BR9200430A (pt) 1992-10-13
NZ241541A (en) 1996-05-28
IL100897A0 (en) 1992-11-15
CA2060954A1 (en) 1992-08-10
AU652798B2 (en) 1994-09-08
EP0499142A3 (en) 1993-05-05
US5366967A (en) 1994-11-22
IE920426A1 (en) 1992-08-12
NO920503D0 (no) 1992-02-07
HU209609B (en) 1994-09-28
HUT60438A (en) 1992-09-28
ZA92891B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
KR920016093A (ko) 흡입된 비스테로이드성 소염약제에 의한 흡입된 루프이뇨제의 항반응성-천식치료 효과의 강화
KR920016086A (ko) 흡입용의 반응억제성 천식치료 활성을 갖는 비스테로이드성 소염제
DE69211036D1 (de) Topisch anzuwendendes Arzneimittel enthaltend Ketoprofenlysinat
Wallace et al. Nitric oxide‐releasing non‐steroidal anti‐inflammatory drugs: A novel approach for reducing gastrointestinal toxicity
KR880002502A (ko) 산에 민감한 유익한 약제의 투여용 제형(劑形)
BR9909705A (pt) Recipiente para alimentos com múltiplas camadas
DE3475691D1 (en) Injectable solution for the treatment of inflammations
KR930001896A (ko) 디클로페낙 나트륨 경고제
KR890007721A (ko) 맛 은폐를 위한 수단을 포함하는 저작가능한 의약 정제
KR910009267A (ko) 우울증의 치료방법
Liang et al. Hypoxia, hypotension, and bradycardia induced by povidone‐iodine ingestion: A pediatric case report and literature review
KR890006665A (ko) 항-hiv 활성, 3'-아지도-2,6-디아미노푸린-2',3'-디데옥시리보사이드
KR890007717A (ko) 약제 디스펜서
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR910014337A (ko) d-2-(6-메톡시-2-나프릴)-프로피온산의 광학활성 유도체와 이것을 함유한 약제학적 조성물
Aston et al. Influence of route and concentration of ethanol upon central depressant effect in the mouse
Bolo Substance abuse and anxiety disorders.
Committee on Drugs Camphor revisited: Focus on toxicity
KR870000932A (ko) 치료용 약쑥 권연
Podolsky Pneumonia associated with the ingestion of petroleum products by children
Mann et al. Once-daily treatment of rheumatoid arthritis with choline magnesium trisalicylate
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
JPS621640U (ko)
KR900004496A (ko) 크레오소트-함유 의약품 포장용 알루미늄 라미네이트
Denham et al. Long acting phenothiazines.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid